院内心搏骤停后一年生存率:系统评价与Meta分析
该系统评价与Meta分析检索截至2018年3月9日已发表数据,纳入40项研究,定量汇总院内心搏骤停后一年生存率。汇总一年生存率为13.4%(95%PI 5.6-28.8%,I2=100%)。亚组分析显示心脏病房患者一年生存率为39.3%(16.1%-68.6%),非心脏入院特征者为10.7%(4.4%-23.6%)。数据覆盖1985-2018年,10年OR为1.70(95%CI 1.04-2.76),提示该期间生存率有适度改善。作者认为院内心搏骤停后一年生存率差,心脏病房入院者更高,研究人群特征可能揭示异质性问题。
要点
- 院内心搏骤停后汇总一年生存率为13.4%(95%PI 5.6-28.8%,I2=100%),研究间异质性极高。
- 心脏病房入院患者一年生存率为39.3%(16.1%-68.6%),非心脏入院特征者为10.7%(4.4%-23.6%)。
- 1985-2018年间一年生存率有适度改善,10年OR为1.70(95%CI 1.04-2.76)。
- 作者认为院内心搏骤停后一年生存率差,心脏病房入院者生存更高。
- 作者认为研究IHCA人群特征可能揭示异质性与过去数十年生存停滞的问题。
适用人群与场景
- 院内心搏骤停患者,数据覆盖1985-2018年。
- 亚组分析包括心脏病房入院患者与非心脏入院特征患者。
研究设计与关键结果
- 研究类型为系统评价与Meta分析,纳入40项研究,检索截至2018年3月9日。
- 院内心搏骤停后汇总一年生存率为13.4%(95%PI 5.6-28.8%,I2=100%)。
- 心脏病房患者一年生存率为39.3%(16.1%-68.6%)。
- 非心脏入院特征患者一年生存率为10.7%(4.4%-23.6%)。
- 数据覆盖1985-2018年,10年OR为1.70(95%CI 1.04-2.76),显示该期间生存率有适度变化。
证据类型、等级与局限
- 证据类型为系统评价与Meta分析,汇总比例采用95%预测区间(95%PI)。
- 研究间异质性用I2统计量和DerSimonian-Laird估计τ2评估,I2=100%。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为院内心搏骤停后一年生存率差,心脏病房入院者生存更高。
- 作者认为研究IHCA人群特征可能揭示异质性与过去数十年生存停滞的问题。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: In-hospital cardiac arrest is a major adverse event with an incidence of 1-6/1000 admissions. It has been poorly researched and data on survival is limited. The outcome of interest in IHCA research is predominantly survival to discharge, however recent guidelines warrant for more long-term outcomes. In this systematic review we sought to quantitatively summarize one-year survival after in-hospital cardiac arrest.
METHODS: For this systematic review and meta-analysis we performed a systematic search of all published data on one-year survival after IHCA up to March 9th, 2018. Results of the meta-analyses are presented as pooled proportions with corresponding 95% prediction intervals (95%PI). Between-study heterogeneity was assessed using I2 statistic and the DerSimonian-Laird estimator for τ2. Subgroup analyses were performed for cardiac and non-cardiac patients.
RESULTS: We included 40 studies in our systematic review and meta-analysis. The pooled one-year survival after in-hospital cardiac arrest was 13.4% (95%PI: 5.6-28.8%, I2 = 100%). Subgroup analysis of cardiac patients revealed a one-year survival of 39.3% (16.1%-68.6%) in patients with a non-cardiac admission characteristic one-year survival was 10.7% (4.4%-23.6%). These data cover the period 1985-2018 and show a modest change in survival over that period (10-year OR: 1.70, 95% CI: 1.04-2.76).
DISCUSSION: One-year survival after in-hospital cardiac arrest is poor. Survival is higher in patients admitted to cardiac wards. The time trend between 1985-2018 has shown a modest improvement in one-year survival rates. Research into IHCA population characteristics might elicit the issue of heterogeneity and stagnated survival over the past decades.
参考来源
- Schluep M, Gravesteijn BY, Stolker RJ, et al. One-year survival after in-hospital cardiac arrest: A systematic review and meta-analysis. Resuscitation. 2018. PMID: 30213495. doi:10.1016/j.resuscitation.2018.09.001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。